Australia TGA Brief

Headline

TGA issues safety alert on FluMist age-range administration errors in children under 2 years

Executive Summary

Australia's Therapeutic Goods Administration issued a safety alert on June 5, 2026 identifying reports of FluMist being administered in error to children under 2 years of age. FluMist is not indicated for that age group. The TGA is directing healthcare providers to verify the approved age range before administration.

Key Regulatory Signals

• Administration Error Reports: TGA has identified multiple reports of FluMist given to children under 2 years, outside the product's approved indicated age range.
• Product Indication Boundary: FluMist's approved indication does not include children under 2 years of age; administration in that cohort constitutes an off-label use with associated safety risk.
• Provider Action Required: Healthcare professionals dispensing or administering FluMist must confirm patient age against the approved product information before administration.
• Adverse Event Reporting: TGA's alert implies ongoing signal monitoring; providers should report any suspected adverse events in affected patients through the TGA's adverse event reporting system.

Regulatory Delta

- No direct TGA precedent for a FluMist-specific age-range alert exists in recent TGA safety communications; this represents a new product-specific signal for this vaccine.

- The alert identifies a real-world administration error pattern, not a product formulation defect. The compliance burden falls on dispensing and clinical workflows.

- The U.S. FDA-approved FluMist Quadrivalent label similarly restricts use to individuals aged 2 through 49 years, placing the TGA's position in line with the originating regulatory baseline.

Materiality Classification

HIGH — A TGA safety alert identifying active administration errors in a pediatric population constitutes a binding safety communication requiring immediate review of dispensing and administration protocols by all providers handling FluMist.

Intelligence Outlook

Monitor the TGA safety updates page at tga.gov.au for any follow-on regulatory action, including product information amendments or Dear Healthcare Professional communications, related to this FluMist age-range signal.